For example, the expression of SERPINB9, a potential drug target and a member of the T-cell dysfunction signature genes, is upregulated in tumor cells by interferon gamma (IFNγ, encoded by the IFNG gene) in the tumor microenvironment3,4. This evidence concerns the gene SERPINB9 and neoplasm.